Research

NYU Langone Scientists Identify Key Factor that Maintains Stem Cell Identity

September 25, 2014 (All day)
A protein implicated in several cancers appears to play a pivotal role in keeping stem cells in an immature "pluripotent" state, according to a new study by NYU Langone Medical Center scientists. The study is published online today in Cell Reports.
 

NYU Langone Scientists Report Reliable and Highly Efficient Method for Making Stem Cells

September 22, 2014 (All day)

 

NEW YORK, September 18, Scientists at NYU Langone Medical Center have found a way to  boost dramatically the efficiency of the process for turning adult cells into so-called pluripotent stem cells by combining three well-known compounds, including vitamin C.

Jeffrey N. Weiser, MD, Appointed Chair of the Department of Microbiology at NYU Langone Medical Center

September 17, 2014 (All day)
NYU Langone Medical Center announced today that Jeffrey N. Weiser, MD, has been appointed as the new chair of the Department of Microbiology, effective January 1, 2015. 
 
An internationally recognized expert in the molecular basis of infectious disease, Dr. Weiser hails from the University of Pennsylvania’s Perelman School of Medicine, where he has been a professor of microbiology and pediatrics. 
 

Targeted Immune System Booster Removes Toxic Proteins in Mouse Model of Alzheimer’s Disease

September 8, 2014 (All day)

Alzheimer’s disease experts at NYU Langone Medical Center and elsewhere are reporting success in specifically harnessing a mouse’s immune system to attack and remove the buildup of toxic proteins in the brain that are markers of the deadly neurodegenerative disease.

NYU Langone Medical Center to Lead Research to Develop Breath Test for Chronic Obstructive Pulmonary Disease

August 25, 2014 (All day)

NYU Langone Medical Center will lead a new clinical initiative -- funded by a $225,000 grant from The National Institutes of Health -- to determine a breath test’s effectiveness to identify volatile organic compounds (VOCs) in human breath that are biomarkers of chronic obstructive pulmonary disease (COPD). The study will employ patented technology developed by Menssana Research, a leading developer of advanced new breath tests for early detection of a wide variety of illnesses and diseases, and the principal recipient of the NIH grant.

Early Antibiotic Exposure Leads to Lifelong Metabolic Disturbances in Mice

August 14, 2014 (All day)

A new study published today in Cell suggests that antibiotic exposure during a critical window of early development disrupts the bacterial landscape of the gut, home to trillions of diverse microbes, and permanently reprograms the body's metabolism, setting up a predisposition to obesity. Moreover, the study shows that it is altered gut bacteria, rather than the antibiotics, driving the metabolic effects.
 

Researchers Identify a Brain 'Switchboard' Important in Attention and Sleep

August 14, 2014 - 12:00pm

Researchers at NYU Langone Medical Center and elsewhere, using a mouse model, have recorded the activity of individual nerve cells in a small part of the brain that works as a "switchboard," directing signals coming from the outside world or internal memories. Because human brain disorders such as schizophrenia, autism, and post-traumatic stress disorder typically show disturbances in that switchboard, the investigators say the work suggests new strategies in understanding and treating them.

Drug Target Identified for Common Childhood Blood Cancer

July 31, 2014 (All day)
Thumbnail: 

In what is believed to be the largest genetic analysis of what triggers and propels progression of tumor growth in a common childhood blood cancer, researchers at NYU Langone Medical Center report that they have identified a possible new drug target for treating the disease.

T-cell acute lymphoblastic leukemia is one of the most common and aggressive childhood blood cancers. An estimated quarter of the 500 adolescents and young adults diagnosed with the cancer each year in the U.S. fail to achieve remission with standard chemotherapy drugs.